TLRYJune 8, 2026 at 12:15 AM UTCPharmaceuticals, Biotechnology & Life Sciences

Brewdog Bite: Tilray's Craft Beer Strategy Faces Fresh Doubts

Read source article

What happened

A new report from The Motley Fool argues that Tilray's acquisition of craft brewer Brewdog is already backfiring, citing collapsing UK sales. This aligns with Tilray's own Q2 FY26 results showing beverage net revenue fell from $63.1M to $50.1M year-over-year, with gross margins compressing from 40% to 31%. The DeepValue master report had already flagged craft beer softness as a key risk, noting that beverage margins near 30% were a threshold for the bear scenario. The new data suggests the deterioration may be accelerating, particularly in the core UK market, raising questions about the strategic rationale for the acquisition. If sustained, this could force further impairments and undermine the broader diversification thesis.

Implication

The evolving data reinforces that Tilray's beverage platform is not providing the expected stability or growth, increasing the probability of the bear scenario where margins remain near 30% and the segment becomes a cash drain. Investors should monitor upcoming quarters for any sign of stabilization; without it, the case for owning Tilray rests almost entirely on international cannabis optionality and a modest net cash position, which alone do not justify the current valuation. A re-assessment is warranted if Q3 FY26 beverage margins fail to improve sequentially.

Thesis delta

The thesis shifts toward higher probability of the bear case, as the craft beer weakness—previously a monitoring point—now appears to be worsening faster than modeled. Beverage segment underperformance, if sustained, increases the risk that Tilray fails to deliver FY26 adjusted EBITDA guidance and reverts to negative free cash flow, undermining the baseline scenario.

Confidence

high